Course #: 010-1024
Price: $9.00Take the Exam
CE Credit Hours: 1.00 CPEUs
Commission on Dietetic Registration (CDR) - Provider #21328, Activity #163574 approved for 1.00 CPEU.
CPEU Course Description
Parkinson’s disease (PD) is the second most prevalent neurodegenerative disease of the central nervous system (CNS). This CPEU course presents findings in metabolomics biomarkers research and abnormal metabolic pathways in PD, along with discussing the correlation between metabolomic changes and clinical conditions of PD.
An RD was involved in the creation of this course.
Article Author: Yaping Shao, Ph.D. and Weidong Le, M.D., Ph.D.
Exam writer: Tiev LaGuire, M.S.
CPEU Course Objectives
1. Explain the proposed hypothesis for the pathogenesis of PD.
2. Identify which molecule has been shown to have high accuracy in distinguishing PD, including early onset, from controls.
3. Illustrate how bilirubin is involved in the predictability of the different stages of PD.
4. List three amino acids for which the metabolism appear to be downregulated with the beginning of alpha-Syn aggregation during the onset of the neurodegenerative processes in PD.
This course expires on 05/31/2024
CPE Level: II
Learning Codes: 3010, 3060, 3090, 5300
Performance Indicators (RDN): 6.2.5, 8.1.3 , 8.1.4 , 8.1.5
Performance Indicators (NTDR): 6.2.5, 8.1.3 , 8.1.4 , 8.3.1
Course Date: 2019-07-20
Our courseware includes the text content found on our websites as well as video, audio, and exam questions that make up our courses. You can link to and access our courseware free of charge for personal use. You may not modify or redistribute our courseware under any circumstances.
Although we allow free access for personal use, you may not use our courseware for any commercial purposes without an agreement in place. This includes (but is not limited to) using our courseware for internal training, redistributing our courseware for sale, and copying all or parts of any of our courseware.
If you're interested in licensing our content for commercial purposes or have any other questions, please contact firstname.lastname@example.org.
We will disclose, in advance, any proprietary interest in any product, instrument, device, service, or material to be discussed during the learning event, as well as the source of any third-party compensation related to the presentation. This policy applies to both our organization and contractors. If such proprietary/financial interests exist, we will publish a disclaimer in marketing or instructional materials for a course.
No conflict of interest or relevant financial relationship was identified for this learning activity for individuals in a position to control content.
In order to view this course, you will need to be able to view a PDF document for the course material. If your device doesn't have the capability to view a PDF, you can click here to download Adobe Acrobat for free.
If you require ADA or other special needs accommodations, please contact us by email: email@example.com or by phone 1-800-413-9373, so arrangements can be made.
The board approval status information is provided based on our current understanding of the licensing agencies. Please note that it is the responsibility of each licensee to verify acceptance of our courses with their licensing agency.